This article shows Celgene from several angles, both good and bad - very strong growth, but also very pricey. The unanswered question is, can it continue its growth?
Is Celgene's Stock Cheap by the Numbers?
By Anand Chokkavelu, CFA
www.fool.com
May 19, 2011
.
.
.
(Here's the article's conclusion)
.
The bottom lineThe pile of numbers we've plowed through has shown us the price multiples shares of Celgene are trading at, the volatility of its operational performance, and what kind of growth profile it has -- both on an absolute and a relative basis.
The more consistent a company's performance has been and the more growth we can expect, the more we should be willing to pay. We've gone well beyond looking at a 30.8 P/E ratio, and despite the large price multiples, if Celgene can get its impressive growth going at a good clip, it may be worth looking into. If you find Celgene's numbers or story compelling, don't stop. Continue your due diligence process until you're confident one way or the other. As a start, add it to My Watchlist to find all of our Foolish analysis.
Full article: http://www.fool.com/investing/high-growth/2011/05/19/is-celgenes-stock-cheap-by-the-numbers.aspx
Gold is $1,581/oz today. When it hits $2,000, it will be up 26.5%. Let's see how long that takes. - De 3/11/2013 - ANSWER: 7 Years, 5 Months
| 